Abstract

Background: To develop a digital algorithm for quantitative assessment of surface methylene blue staining in whole lymph nodes and validate a semi-quantitative visual scoring method for patient-side use.Methods: Lymph nodes from canine patients with spontaneous tumors undergoing sentinel lymph node mapping were prospectively assessed ex vivo and photographed. Using an open-source computer-based imaging software, an algorithm was developed for quantification of staining based on a signal-to-background ratio. Next, two blinded observers evaluated images and assigned a semi-quantitative visual score based on surface staining (0—no blue stain, 1−1–50% stained, and 2−51–100% stained) and those results were compared to the established quantitative standard.Results: Forty-three lymph nodes were included. Image analysis successfully quantified blue staining and differentiated from normal lymph node tissue in all cases. Agreement between observers using the Kappa coefficient demonstrated strong agreement (k = 0.8581, p < 0.0001) between semi-quantitative visual scoring and image analysis. There was substantial interobserver and intraobserver agreement for the scoring system (k = 0.7340, p < 0.0001 and k = 0.8983, p < 0.0001, respectively).Conclusion: A digital algorithm using an open-source software was simple and straightforward to use for quantification of blue staining. The use of a semi-quantitative visual scoring system shows promise for a simple, objective, repeatable assessment of methylene blue staining at the time of surgery. This study demonstrates reliable and repeatable methods for blue staining quantification thereby providing a novel and objective reporting mechanism in scientific research involving sentinel lymph node mapping.

Highlights

  • Sentinel lymph nodes (SLN) represent the primary site of solid tumor drainage and are valuable indicators for cancer staging and treatment recommendations [1, 2]

  • The purpose of this study is to develop a digital algorithm for quantitative assessment of surface methylene blue staining in whole lymph nodes using an open-access program for image analysis and to validate a semi-quantitative visual scoring method for patient-side use

  • A total of 43 lymph nodes were collected from 25 clinical cases of patients undergoing lymph node extirpation with SLN mapping

Read more

Summary

Introduction

Sentinel lymph nodes (SLN) represent the primary site of solid tumor drainage and are valuable indicators for cancer staging and treatment recommendations [1, 2]. Validating Lymph Node Staining Assessment involving a combination of radioisotopes, blue dyes and/or fluorescence to increase reliability [4,5,6,7]. In specific countries and facilities, methylene blue dye is used alone for SLN mapping in light of its cost effectiveness, accessibility, and safe outcomes [4, 8, 9]. Breast cancer studies that employ methylene blue dye alone suggest comparable lymphatic uptake and results to other blue dyes [2, 11,12,13,14,15]. To develop a digital algorithm for quantitative assessment of surface methylene blue staining in whole lymph nodes and validate a semi-quantitative visual scoring method for patient-side use

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call